StonvexLoading…
StonvexStonvexStonvexCore line items from ASST's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Annual 2025 2025-09-11 | Annual 2024 2024-12-31 |
|---|---|---|---|
Revenue | $1.51M | $4.22M | $3.65M |
Operating Income | $-241.14M | $-11.86M | $-22.65M |
Net Income | $-393.60M | $-26.99M | $-21.58M |
EPS (Diluted) | $-9.04 | $-11.74 | $-9.75 |
Total Assets | $745.53M | Not available | $28.20M |
Total Liabilities | $14.29M | Not available | $4.86M |
Cash & Equivalents | $67.50M | $3.92M | $6.16M |
Free Cash Flow OCF − CapEx | $-24.99M | $-18.21M | $-21.62M |
Shares Outstanding | 44.00M | 2.30M | 2.21M |